Clinical Trials Browser

Phase 3 × INDUSTRY × Locally Advanced or Metastatic GC and GCJ Adenocarcinoma × Clear all

NCT07362186 2026-01-23

LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Phase 3 Not yet recruiting

Locally Advanced or Metastatic GC and GCJ Adenocarcinoma